Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Multiple myeloma.

Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Faber EA Jr, Gasparetto C, Huff CA, Kassim A, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Tricot G, Weber DM, Yahalom J, Yunus F; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Oct;9(10):1146-83. No abstract available. Erratum in: J Natl Compr Canc Netw. 2011 Dec 1;9(12):xxv.

PMID:
21975914
2.

Plasmacytoma of the testis in a patient with previous multiple myeloma: is the testis a sanctuary site?

Rosenberg S, Shapur N, Gofrit O, Or R.

J Clin Oncol. 2010 Sep 20;28(27):e456-8. doi: 10.1200/JCO.2009.27.6519. Epub 2010 Aug 2. No abstract available.

PMID:
20679613
3.

NCCN: Multiple myeloma.

Traynor AE, Noga SJ; NCCN Multiple Myeloma Practice Guidelines Panel.

Cancer Control. 2001 Nov-Dec;8(6 Suppl 2):78-87. Review.

PMID:
11760563
4.

[Plasma-cell myeloma. II. New developments in the diagnosis and treatment of the disease].

Barlogie B, Epstein J, Selvanayagam P, Alexanian R.

Gematol Transfuziol. 1992 Jul-Aug;37(7-8):33-9. Review. Russian. No abstract available.

PMID:
1342986
5.

Multiple asymptomatic colon plasmacytomas: a diagnostic and therapeutic dilemma.

Swaika A, Advani PP, Ghosh RN, Jha AK, Jiang L, Ailawadhi S.

Ann Hematol. 2015 Jun;94(6):1061-2. doi: 10.1007/s00277-014-2283-x. Epub 2014 Dec 23. No abstract available.

PMID:
25529595
6.

Multiple myeloma presenting as plasmacytoma of the base of the skull.

Alegre A, Tomás JF, Pinilla I, Gil-Fernández JJ, Fernández-Rañada JM.

Am J Hematol. 1996 May;52(1):60-1. No abstract available.

7.

[Current therapy concepts in patients with multiple myeloma].

Heyll A, Schneider P, Bauser U, Kobbe G, Hünerlitürkoglu A, Aul C, Haas R.

Dtsch Med Wochenschr. 2000 Oct 6;125(40):1201-9. Review. German. No abstract available.

PMID:
11075253
8.

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.

Gertz MA, Lacy MQ, Inwards DJ, Chen MG, Pineda AA, Gastineau DA, Greipp PR, Lust JA, Tefferi A, Witzig TE, Kyle RA, Litzow MR.

Bone Marrow Transplant. 1999 Feb;23(3):221-6.

9.

Complete remission of multiple myeloma.

Lonial S.

Clin Adv Hematol Oncol. 2007 Sep;5(9):671-2, 675. Review. No abstract available.

PMID:
17982407
10.

Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.

Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, Scott GL, Rahemtulla A, Samson D, Apperley JF.

Eur J Haematol. 2005 Nov;75(5):376-83.

PMID:
16191086
11.

Guidelines on the diagnosis and management of multiple myeloma 2005.

Smith A, Wisloff F, Samson D; UK Myeloma Forum; Nordic Myeloma Study Group; British Committee for Standards in Haematology.

Br J Haematol. 2006 Feb;132(4):410-51. No abstract available.

PMID:
16412016
12.

[Multiple myeloma and chronic lymphocytic leukemia].

Labardini-Méndez J, Alexanian R, Barlogie B.

Rev Invest Clin. 1997 May;49 Suppl 1:28-33. Review. Spanish. No abstract available.

PMID:
9380986
13.

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Faiman M, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Liedtke M, Martin T, Omel J, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R.

J Natl Compr Canc Netw. 2017 Feb;15(2):230-269.

PMID:
28188192
14.

[Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].

Shimizu K; Japan Myeloma Study Group.

Rinsho Ketsueki. 2005 Jun;46(6):424-32. Review. Japanese. No abstract available.

PMID:
16447724
15.

Extramedullary plasmacytoma associated with multiple myeloma.

Diwan AG, Gholap NN, Taneja SR.

J Assoc Physicians India. 2003 Feb;51:236-7. No abstract available.

PMID:
12725283
16.

Guidelines for the diagnosis and management of multiple myeloma 2011.

Bird JM, Owen RG, D'Sa S, Snowden JA, Pratt G, Ashcroft J, Yong K, Cook G, Feyler S, Davies F, Morgan G, Cavenagh J, Low E, Behrens J; Haemato-oncology Task Force of British Committee for Standards in Haematology (BCSH) and UK Myeloma Forum.

Br J Haematol. 2011 Jul;154(1):32-75. doi: 10.1111/j.1365-2141.2011.08573.x. Epub 2011 May 14. Review. No abstract available.

PMID:
21569004
17.

Plasma cell myeloma with multiple plasmacytomas.

Wirk B.

Clin Adv Hematol Oncol. 2011 Aug;9(8):633-5. Review. No abstract available.

PMID:
22236994
18.

Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.

Patriarca F, Sperotto A, Filì C, Zaja F, Prosdocimo S, Fanin R.

Haematologica. 2002 Jul;87(7):779-81.

19.

An unusual presentation of extramedullary plasmacytoma in testis and review of the literature.

Turk HM, Komurcu S, Ozet A, Kuzhan O, Günhan O.

Med Oncol. 2010 Dec;27(4):1378-80. doi: 10.1007/s12032-009-9390-x. Epub 2009 Dec 25.

PMID:
20035386
20.

Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.

Siegel DS, Vij R, Jakubowiak AJ.

Clin Adv Hematol Oncol. 2011 Apr;9(4):1-15.

PMID:
21928467

Supplemental Content

Support Center